EUVIMEDEUVIMED entdecken
Crossref

Data‐adaptive and pathway‐based tests for association studies between somatic mutations and germline variations in human cancers

Zhongyuan Chen iD, Han Liang, Peng Wei iD

Genetic Epidemiology · 2023

DOI: 10.1002/gepi.22537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Epidemiology, 2023. Verfasst von Zhongyuan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a disease driven by a combination of inherited genetic variants and somatic mutations. Recently available large‐scale sequencing data of cancer genomes have provided an unprecedented opportunity to study the interactions between them. However, previous studies on this topic have been limited by simple, low statistical power tests such as Fisher's exact test. In this paper, we design data‐adaptive and pathway‐based tests based on the score statistic for association studies between somatic mutations and germline variations. Previous research has shown that two single‐nucleotide polymorphism (SNP)‐set‐based association tests, adaptive sum of powered score (aSPU) and data‐adaptive pathway‐based (aSPUpath) tests, increase the power in genome‐wide association studies (GWASs) with a single disease trait in a case–control study. We extend aSPU and aSPUpath to multi‐traits, that is, somatic mutations of multiple genes in a cohort study, allowing extensive information aggregation at both SNP and gene levels. ‐values from different parameters assuming varying genetic architecture are combined to yield data‐adaptive tests for somatic mutations and germline variations. Extensive simulations show that, in comparison with some commonly used methods, our data‐adaptive somatic mutations/germline variations tests can be applied to multiple germline SNPs/genes/pathways, and generally have much higher statistical powers while maintaining the appropriate type I error. The proposed tests are applied to a large‐scale real‐world International Cancer Genome Consortium whole genome sequencing data set of 2583 subjects, detecting more significant and biologically relevant associations compared with the other existing methods on both gene and pathway levels. Our study has systematically identified the associations between various germline variations and somatic mutations across different cancer types, which potentially provides valuable utility for cancer risk prediction, prognosis, and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genome-Wide Association StudyNeoplasmsHumansCase-Control StudiesCohort StudiesModels, GeneticMutationGerm CellsPolymorphism, Single NucleotidePhenylurea Compounds

Stichwörter der Autor:innen

association studiesdata-adaptive pathway-based testgermline variationssomatic mutations

Substanzen

1-amidino-3-(3-sulfamoylphenyl)ureaPhenylurea Compounds

Autor:innen und Institutionen

  • Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Zhongyuan Chen, Peng Wei

Zitieren

APA

Chen, Z., Liang, H., & Wei, P. (2023). Data‐adaptive and pathway‐based tests for association studies between somatic mutations and germline variations in human cancers. Genetic Epidemiology. https://doi.org/10.1002/gepi.22537

Vancouver

Chen Z, Liang H, Wei P. Data‐adaptive and pathway‐based tests for association studies between somatic mutations and germline variations in human cancers. Genetic Epidemiology. 2023. doi:10.1002/gepi.22537

BibTeX
@article{Chen2023,
  author = {Chen, Zhongyuan and Liang, Han and Wei, Peng},
  title = {Data‐adaptive and pathway‐based tests for association studies between somatic mutations and germline variations in human cancers},
  journal = {Genetic Epidemiology},
  year = {2023},
  doi = {10.1002/gepi.22537}
}
Kostenlos starten →